Core Viewpoint - ChipSource Micro has become the only domestic company capable of providing mass-produced mid-to-high-end coating and developing equipment in China [1][2]. Group 1: Industry Context - The photolithography process is crucial in integrated circuit manufacturing, accounting for 50% of production time and 30% of costs. The domestic replacement rate for photolithography machines is less than 3%, while the coating and developing equipment, which is highly monopolized by Japanese companies, has a replacement rate of less than 10% [2][4]. - Coating and developing machines, along with photolithography machines and photoresists, are considered the three essential elements of the photolithography process [2]. Group 2: Company Development - ChipSource Micro was founded in 2002 when the domestic semiconductor market was undeveloped, lacking products, supply chains, and customers. The company has grown from 4-inch and 6-inch wafers to 8-inch and 12-inch, expanding from LED to advanced packaging and front-end fields [2]. - The company successfully went public on the Shanghai Stock Exchange's Sci-Tech Innovation Board in 2019, becoming the first stock from Liaoning Province on this board, and has since become a leader in the domestic coating and developing equipment sector [2]. Group 3: Market Position and Growth Potential - The low domestic replacement rate indicates significant growth potential. ChipSource Micro's front-end equipment covers all process nodes above 28nm, accounting for over 90% of China's mature semiconductor processes. The company has achieved international advanced levels in front-end physical cleaning equipment, becoming the market leader domestically [4]. - In the advanced packaging sector, ChipSource Micro has over 50% market share as a key supplier of mass production equipment, while also expanding into emerging fields like 2.5D and 3D packaging [4]. Group 4: R&D and Innovation - ChipSource Micro has maintained R&D expenses at over 10% of its revenue for several years, with R&D investment reaching 297 million yuan in 2024, a nearly 50% increase year-on-year [4]. - The company emphasizes the complexity of coating and developing equipment, which consists of over 150 units and requires high precision and reliability to avoid affecting the performance of photolithography machines [5].

本文约 5 0 0 0 字，推荐阅读时长 2 0 分钟，欢迎关注新财富公众号。 20世纪60年代，在"两弹一星"工程与"156项重点工程"宏大叙事之下，中国半导体制造设备的国产化征程悄然启动。 1965年，北京建中机器厂（国营700厂）的成立，标志着中国首次系统性布局半导体制造设备的研发。这座藏身于北京东郊的工厂，承载着突破西方技术 封锁的历史使命。在"自力更生"的号召下，国营706厂、707厂也相继落成，整体上形成覆盖单晶炉、扩散炉等原始设备体系。此后数十年间，这些国营 工厂不仅培养了中国首批半导体设备专业人才，更在真空设备、晶体生长技术等领域积累了原始技术储备。 2001年，北京电子控股有限责任公司（北京电控）对上述国营资产进行战略性整合，成立七星电子（北方华创前身），主营半导体设备及精密电子元器 件业务。同年，由北京电控联合国内高校等科研机构，共同出资设立北方微电子，专注于刻蚀机、CVD（化学气相沉积）和PVD（物理气相沉积）设备 研发。这种"制造+研发"的双轨架构，标志着中国半导体设备产业从分散走向集约化发展的开端。 0 1 新中国工业化探索的深刻烙印 中国半导体设备发展史上，2001-2010年，是 ...

丨证券研究报告丨 联合研究丨公司点评丨芯源微（688037.SH） [Table_Title] 芯源微：新产品进展积极顺利，引入龙头拓展市 场增量 报告要点 [Table_Summary] 近期，芯源微发布 2024 年年报及 2025 年一季度报告。 2024 年公司实现营收 17.54 亿元，同比增加 2.13%；实现归母净利润 2.03 亿元，同比减少 19.08%；2025Q1 公司实现营收 2.75 亿元，同比增加 12.74%；实现归母净利润 0.05 亿元， 同比减少 70.89%。 分析师及联系人 [Table_Author] 杨洋 赵智勇 倪蕤 王泽罡 SAC：S0490517070012 SAC：S0490517110001 SAC：S0490520030003 SAC：S0490521120001 SFC：BUW100 SFC：BRP550 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 芯源微（688037.SH） cjzqdt11111 [Table_Title 芯源微：新产品进展积极顺利，引入龙头拓展市 2] 场增量 [Table_S ...

公司研究 证 券 研 究 报 告 芯源微（688037）2024 年报&2025 年一季报点评 强推（维持） 订单稳健增长，化学清洗&Track 进展顺利 目标价：122.0 元 事项： 评论： [ReportFinancialIndex] 主要财务指标 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 1,754 | 2,046 | 2,748 | 3,598 | | 同比增速(%) | 2.1% | 16.7% | 34.3% | 30.9% | | 归母净利润(百万) | 203 | 261 | 418 | 606 | | 同比增速(%) | -19.1% | 28.7% | 60.2% | 45.0% | | 每股盈利(元) | 1.01 | 1.30 | 2.08 | 3.01 | | 市盈率(倍) | 95 | 73 | 46 | 32 | | 市净率(倍) | 7.1 | 6.7 | 6.0 | 5.3 | 资料来源：公司公告，华创证券预测 注：股价为 2025 年 4 月 30 日 ...

Core Insights - The company reported a slight increase in revenue but a significant decline in net profit for the year 2024, indicating challenges in maintaining profitability amidst rising costs and increased R&D investments [1][2]. Financial Performance - Revenue for 2024 reached ¥1,753,605,965.73, a 2.13% increase from ¥1,716,969,907.58 in the previous year, demonstrating stability in a competitive semiconductor equipment market [2]. - Net profit attributable to shareholders was ¥202,811,998.36, down 19.08% year-on-year, primarily due to increased R&D spending and rising operational costs [2]. - The company's non-recurring net profit fell by 60.83% to ¥73,306,592.00, highlighting challenges in core business profitability [2]. Earnings Per Share - Basic earnings per share decreased to ¥1.01, a 44.51% drop from ¥1.82, influenced by lower net profit and an increase in total shares due to stock incentives [3]. - The non-recurring earnings per share fell by 72.79% to ¥0.37, indicating a significant decline in core business profitability [3]. Cost and Expense Analysis - Sales expenses rose by 22.44% to ¥89,833,591.30, driven by increased employee compensation and service fees as the company expanded [4]. - Management expenses increased by 36.93% to ¥249,302,182.63, reflecting higher costs associated with business expansion [4]. - R&D expenses surged by 49.93% to ¥296,653,098.59, representing 16.92% of revenue, up from 11.52% the previous year, indicating a strong focus on innovation [4][6]. Cash Flow and Financial Health - Net cash flow from operating activities improved to ¥441,809,413.08, a turnaround from a negative cash flow of ¥562,876,699.27 the previous year, indicating enhanced cash generation capabilities [5]. - Net cash flow from investing activities was -¥201,463,591.83, an improvement from -¥504,561,073.41, suggesting a slowdown in fixed asset investments [5]. - Net cash flow from financing activities decreased by 12.80% to ¥609,966,263.66, primarily due to increased short-term loan repayments [5]. R&D and Personnel Growth - R&D expenses reached ¥297 million, a 49.93% increase, with R&D investment as a percentage of revenue rising by 5.40 percentage points [6]. - The number of R&D personnel increased by 28.57% to 459, with total R&D personnel compensation rising to ¥103.37 million, reflecting the company's commitment to innovation [7].